Alternative Splicing of Pre-mRNA Matters in Oral Diseases

被引:0
作者
Yue, Mingyang [1 ]
Jia, Rong [1 ]
机构
[1] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ,Key Lab Oral Biomed, State Key Lab Oral & Maxillofacial Reconstruct & R, Wuhan 430072, Peoples R China
关键词
Alternative splicing; oral diseases; isoforms; Pre-mRNA; pathogenesis; splicing factors; SQUAMOUS-CELL CARCINOMA; DIACYLGLYCEROL KINASE-ALPHA; GENE-EXPRESSION; VARIANT; IDENTIFICATION; MCL-1; STAT3; EXON; FIBRONECTIN; REGULATOR;
D O I
10.2174/0115665232302948240718050212
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Alternative splicing (AS) of pre-mRNA occurs widely in human genes to produce multiple isoforms with different or even opposite functions. Aberrant AS is often associated with gene mutations and can be corrected by gene therapy. Oral diseases are important public health problems worldwide. Accumulated pieces of evidence demonstrate that AS of pathogenic genes plays key roles in some oral diseases. However, considering the extensiveness and complexity of AS, it may affect the initiation and development of oral diseases deeply and widely. This review describes the diversity of AS and resulting isoforms in genetic, infectious, and malignant oral diseases and highlights the key roles of AS in determining the function of isoforms and the occurrence and progression of these diseases. The studies of alternative splicing may provide great opportunities for the understanding and treatment of oral diseases.
引用
收藏
页数:11
相关论文
共 79 条
[1]   Phenotypic changes in dentition of Runx2 homozygote-null mutant mice [J].
Åberg, T ;
Cavender, A ;
Gaikwad, JS ;
Bronckers, ALJJ ;
Wang, XP ;
Waltimo-Sirén, J ;
Thesleff, I ;
D'Souza, RN .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 (01) :131-139
[2]   EVALUATION OF CD44 VARIANT EXPRESSION IN ORAL, HEAD AND NECK SQUAMOUS CELL CARCINOMAS USING A TRIPLE APPROACH AND ITS CLINICAL SIGNIFICANCE [J].
Athanassiou-Papaefthymiou, M. ;
Shkeir, O. ;
Kim, D. ;
Divi, V. ;
Matossian, M. ;
Owen, J. H. ;
Czerwinski, M. J. ;
Papagerakis, P. ;
McHugh, J. ;
Bradford, C. R. ;
Carey, T. E. ;
Wolf, G. T. ;
Prince, M. E. ;
Papagerakis, S. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2014, 27 (03) :337-349
[3]   Identification of a novel splice variant of the human anti-apoptosis gene survivin [J].
Badran, A ;
Yoshida, A ;
Ishikawa, K ;
Goi, T ;
Yamaguchi, A ;
Ueda, T ;
Inuzuka, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 314 (03) :902-907
[4]   MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain [J].
Bae, J ;
Leo, CP ;
Hsu, SY ;
Hsueh, AJW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25255-25261
[5]   Alternative splicing as a regulator of development and tissue identity [J].
Baralle, Francisco E. ;
Giudice, Jimena .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2017, 18 (07) :437-451
[6]   Alternative Splicing Generates a Diacylglycerol Kinase α Transcript That Acts as a Dominant-Negative Modulator of Superoxide Production in Localized Aggressive Periodontitis [J].
Batista, Eraldo L., Jr. ;
Kantarci, Alpdogan I. ;
Hasturk, Hatice ;
Van Dyke, Thomas E. .
JOURNAL OF PERIODONTOLOGY, 2014, 85 (07) :934-943
[7]   The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development [J].
Bebee, Thomas W. ;
Park, Juw Won ;
Sheridan, Katherine I. ;
Warzecha, Claude C. ;
Cieply, Benjamin W. ;
Rohacek, Alex M. ;
Xing, Yi ;
Carstens, Russ P. .
ELIFE, 2015, 4
[8]   Exon skipping in Mcl-1 results in a Bcl-2 homology domain 3 only gene product that promotes cell death [J].
Bingle, CD ;
Craig, RW ;
Swales, BM ;
Singleton, V ;
Zhou, P ;
Whyte, MKB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :22136-22146
[9]   Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 [J].
Burns, K ;
Janssens, S ;
Brissoni, B ;
Olivos, N ;
Beyaert, R ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :263-268
[10]   Survivin 2α:: a novel survivin splice variant expressed in human malignancies [J].
Caldas, Hugo ;
Honsey, Laura E. ;
Altura, Rachel A. .
MOLECULAR CANCER, 2005, 4 (1)